These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 16536308)
1. [Study on the postive frequency and distribution of glutamic acid decarboxylase antibody in phenotypic type 2 diabetec patients]. Li X; Zhou ZG; Haung G; Peng J; Yan X; Yang L; Wang JP; Deng ZM Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):800-3. PubMed ID: 16536308 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285 [TBL] [Abstract][Full Text] [Related]
3. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults]. Li X; Huang G; Yan X; Yang L; Zhou ZG Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648 [TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults. Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309 [TBL] [Abstract][Full Text] [Related]
5. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Lindholm E; Hallengren B; Agardh CD Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992 [TBL] [Abstract][Full Text] [Related]
6. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults]. Huang YY; Huang P; Lou HL Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925 [TBL] [Abstract][Full Text] [Related]
7. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults. Li X; Yang L; Zhou Z; Huang G; Yan X Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults. Zhou Z; Ouyang L; Peng J; Yang W; Wang J; Zhu X; Wu H; Dyrberg T Chin Med J (Engl); 1999 Jun; 112(6):554-7. PubMed ID: 11601338 [TBL] [Abstract][Full Text] [Related]
9. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria. Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R; Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073 [TBL] [Abstract][Full Text] [Related]
11. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes. Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504 [TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase. Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268 [TBL] [Abstract][Full Text] [Related]
13. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients]. Zhang C; Zhou ZG; Lin J; Huang G; Wang JP; Zhang DM; Zhou M; Yang XL Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):797-801. PubMed ID: 18756979 [TBL] [Abstract][Full Text] [Related]
14. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients]. Reinsch B; Zimmy S; Schatz H; Pfohl M Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530 [TBL] [Abstract][Full Text] [Related]
15. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies]. Yang L; Zhou ZG; Huang G; Yan X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes. Unnikrishnan AG; Singh SK; Sanjeevi CB Ann N Y Acad Sci; 2004 Dec; 1037():118-21. PubMed ID: 15699503 [TBL] [Abstract][Full Text] [Related]
17. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E; Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset. Rattarasarn C; Diosdado MA Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726 [TBL] [Abstract][Full Text] [Related]
19. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice. De Aizpurua HJ; French MB; Chosich N; Harrison LC J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]